Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

A population genetic model for the initial spread of partially resistant malaria parasites under anti-malarial combination therapy and weak intrahost competition.

Kim Y, Escalante AA, Schneider KA.

PLoS One. 2014 Jul 9;9(7):e101601. doi: 10.1371/journal.pone.0101601. eCollection 2014.

2.

The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum.

Escalante AA, Smith DL, Kim Y.

Trends Parasitol. 2009 Dec;25(12):557-63. doi: 10.1016/j.pt.2009.09.008. Epub 2009 Oct 26. Review.

3.

Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reports.

Cottrell G, Musset L, Hubert V, Le Bras J, Clain J; Atovaquone-Proguanil Treatment Failure Study Group..

Antimicrob Agents Chemother. 2014 Aug;58(8):4504-14. doi: 10.1128/AAC.02550-13. Epub 2014 May 27.

4.

Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya.

McCollum AM, Schneider KA, Griffing SM, Zhou Z, Kariuki S, Ter-Kuile F, Shi YP, Slutsker L, Lal AA, Udhayakumar V, Escalante AA.

Malar J. 2012 Mar 22;11:77. doi: 10.1186/1475-2875-11-77.

5.

The selection landscape of malaria parasites.

Mackinnon MJ, Marsh K.

Science. 2010 May 14;328(5980):866-71. doi: 10.1126/science.1185410. Review.

PMID:
20466925
6.

Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.

Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N.

Acta Trop. 2016 Dec;164:329-336. doi: 10.1016/j.actatropica.2016.09.008. Epub 2016 Sep 17.

PMID:
27647575
7.

An analytical model for genetic hitchhiking in the evolution of antimalarial drug resistance.

Schneider KA, Kim Y.

Theor Popul Biol. 2010 Sep;78(2):93-108. doi: 10.1016/j.tpb.2010.06.005. Epub 2010 Jun 19.

8.

Malaria research. Inbred parasites may spur resistance.

Schmidt KF.

Science. 1995 Sep 22;269(5231):1670. No abstract available.

PMID:
7569890
9.

Intercontinental spread of pyrimethamine-resistant malaria.

Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T.

Science. 2004 Aug 20;305(5687):1124.

10.

A unique methodology for detecting the spread of chloroquine-resistant strains of Plasmodium falciparum, in previously unreported areas, by analyzing anophelines of malaria endemic zones of Orissa, India.

Mohanty A, Swain S, Singh DV, Mahapatra N, Kar SK, Hazra RK.

Infect Genet Evol. 2009 Jul;9(4):462-7. doi: 10.1016/j.meegid.2009.01.005. Epub 2009 Jan 20.

PMID:
19460311
11.

Selection of drug resistant mutants from random library of Plasmodium falciparum dihydrofolate reductase in Plasmodium berghei model.

Tipsuwan W, Srichairatanakool S, Kamchonwongpaisan S, Yuthavong Y, Uthaipibull C.

Malar J. 2011 May 10;10:119. doi: 10.1186/1475-2875-10-119.

12.

Heterogeneous distribution of Plasmodium falciparum drug resistance haplotypes in subsets of the host population.

Schoepflin S, Marfurt J, Goroti M, Baisor M, Mueller I, Felger I.

Malar J. 2008 May 6;7:78. doi: 10.1186/1475-2875-7-78.

13.

Genetic and biochemical aspects of drug resistance in malaria parasites.

Hayton K, Su XZ.

Curr Drug Targets Infect Disord. 2004 Mar;4(1):1-10. Review.

PMID:
15032630
14.

Plasmodium falciparum: differential selection of drug resistance alleles in contiguous urban and peri-urban areas of Brazzaville, Republic of Congo.

Tsumori Y, Ndounga M, Sunahara T, Hayashida N, Inoue M, Nakazawa S, Casimiro P, Isozumi R, Uemura H, Tanabe K, Kaneko O, Culleton R.

PLoS One. 2011;6(8):e23430. doi: 10.1371/journal.pone.0023430. Epub 2011 Aug 15.

15.

Analysis of genetic mutations associated with anti-malarial drug resistance in Plasmodium falciparum from the Democratic Republic of East Timor.

de Almeida A, Arez AP, Cravo PV, do Rosário VE.

Malar J. 2009 Apr 9;8:59. doi: 10.1186/1475-2875-8-59.

16.
17.

Plasmodium falciparum malaria: Convergent evolutionary trajectories towards delayed clearance following artemisinin treatment.

Wilairat P, Kümpornsin K, Chookajorn T.

Med Hypotheses. 2016 May;90:19-22. doi: 10.1016/j.mehy.2016.02.022. Epub 2016 Mar 4.

PMID:
27063079
18.

Changes in drug sensitivity and anti-malarial drug resistance mutations over time among Plasmodium falciparum parasites in Senegal.

Van Tyne D, Dieye B, Valim C, Daniels RF, Sène PD, Lukens AK, Ndiaye M, Bei AK, Ndiaye YD, Hamilton EJ, Ndir O, Mboup S, Volkman SK, Wirth DF, Ndiaye D.

Malar J. 2013 Dec 6;12:441. doi: 10.1186/1475-2875-12-441.

19.

[Mechanisms and dynamics of drug resistance in Plasmodium falciparum].

Le Bras J.

Bull Soc Pathol Exot. 1999 Sep-Oct;92(4):236-41. Review. French.

PMID:
10572658

Supplemental Content

Support Center